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Introduction
Apart from classical pathway of the complement acti-
vation associated with antibodies, there is also so
called alternative pathway for complement system
activation. In the alternative pathway the cascade of
activation leading to formation of membrane attack
complex – MAC and increase in inflammatory reac-
tion could occur spontaneously and is regulated by the
action of specific factors. These regulators might be
synthesized by leucocytes in the response to C5a com-
plement component, and also when there is insuffi-
cient inhibition of complement cascade by certain fac-
tors as: decay-accelerating factor (DAF), membrane
cofactor protein (MCP), complement receptor 1 –
CR1. There are synthesized and attached to the surface
of attacked cells (in case of immunologic reaction) [1]. 
In vivo studies in the endometrium have shown
increased expression of genes controlling the comple-
ment activation during secretory phase of the cycle
compared to proliferative phase [2]. In an in vitro stud-
ies it was proven that  heparin-binding epidermal
growth factor-like growth factor (HB-EGF) influences
the expression of DAF, MCP in the cells of luminal and
glandular endometrium [3,4]. Endometrium also syn-
thesizes the C3 component of the complement system,
which is one of the early and key components of the
complement system cascade [5]. C3 is a common ele-
ment for the classic and alternative pathways of the
complement activation. It was shown that blocking C3
gene or protein inhibits the activation of the comple-
ment, which had an evident positive effect on decreased
resorbtion rates of fetuses in mice model [6].
Explanation of the negative effect of C3 comple-
ment component on embryos, might come from stud-
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Abstract: Human endometrium, deciuda and placenta have been shown to express factors that inhibit the complement acti-
vation cascade – decay-accelerating factor (DAF), membrane cofactor protein (MCP) and the C3 complement component.
In the following study we have analyzed the transcripts levels for DAF, MCP and heparin-binding epidermal growth factor-
like growth factor (HB-EGF), the C3 complement component and receptor for vascular endothelial growth factor
(VEGFR1) as markers of endometrial unbalance between factors activating the complement system in women with con-
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comprised the control group. RNA was isolated from endometrial samples. Transcripts levels of DAF and MCP was high-
er in women with consecutive miscarriages compared to controls, 0.78 vs 5.08 (p<0.001) and 0.25 vs 0.17 (p=0.001) respec-
tively. In consecutive miscarriages group, DAF and MCP expression was correlated with the C3 expression, with r=0.60;
p<0.001 and r= 0.40; p=0.03 respectively. Correlation between DAF and C3 was also noted in controls, 0.70; p=0.001. In
women with two or more consecutive  miscarriages the analysis proved higher expression of genes that encode proteins that
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the complement factors, which like C3 that are synthesized in the endometrium.
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ies on aPL mice showed that decidual cells, in
response to the complement cascade product C5a,
release soluble receptor for vascular endothelial
growth factor (VEGFR1, syn. SFlt1). Decreasing the
availability of vascular endothelial growth factor
(VEGF1) for trophoblast VEGF1 receptors leads to
decrease in the development of vessels, inhibition or
drastic decline in trophoblast invasion and the malde-
velopment of the placenta and the fetus [7]. Authors
also point to an importance of alternative pathway of
the complement activation in enhancement – via a pos-
itive feedback loop – of the inflammatory reaction.
The above observations suggest mechanism in
which, among others, HB-EGF influences the expres-
sion of DAF, MCP. On the other hand, these factors
inhibits the complement cascade, of which the C3
component is the key element. Finally, one of the
results of complement cascade activation is the sFlt1
synthesis. Problems with inadequate expression of
above mentioned factors controlling the complement
cascade might be one of the reasons for unexplained,
consecutive miscarriages. In current study an attempt
was made to compare the expression levels of DAF,
MCP, C3, HB-EGF, and VEGFR1 genes. The correla-
tions between C3 and DAF, MCP transcripts – as
direct inhibitors – of complement cascade and correla-
tions between C3 and VEGFR1 – as cascade propaga-
tors – transcripts  in eutopic endometrium during the
implantation window in non-conceptional cycles in
women with unexplained, consecutive  miscarriage
and healthy, fertile women were studied. 
Materials and methods
The study, which obtained acceptance from Karol Marcinkowski's
Medical University bioethical committee, included 49 reproduc-
tive aged women. The study group consisted of 30 women with
two and more unexplained, consecutive miscarriages, and the
control comprised of 19 women with normal reproductive poten-
tial. The women in a miscarriage group have had at least two con-
secutive unexplained miscarriages in the first trimester of preg-
nancy. This group included 8 women with diagnosed recurrent
miscarriage(e.g. 3 consecutive miscarriages). The control con-
sisted of women that had at least one child, regular menses, with-
out anatomical or functional changes within the endometrium.
The exclusion criteria were: current use of hormonal contracep-
tion, any serious diseases. The age of women, number of miscar-
riages and parity are showed in Table 1. In each woman the
pipelle or hysteroscopic biopsy was used to acquire the
endometrium during the implantation window, which is 7-9 days
after ultrasound confirmed ovulation. 
RNA Isolation. Part of the biopsy was transferred to histology for
evaluation according to Noyes and Hertig criteria [8]; the rest was
placed in RNAlater solution (Qiagen, Germany) and frozen to 
-80°C till RNA isolation. The RNA isolation was conducted with
the use of RNAeasy Protect Mini Kit (Qiagen, Germeny). To elim-
inate the risk of DNA contamination we have used an additional
recommended by the manufacturer RNaseFree DNase Set (Qiagen,
Germany).
Reverse Transcription. For reverse transcription we taken 1μg
previously isolated RNA. Qantity at OD260nm and purity at
OD260/280nm samples was checked spectrophotometrically with-
NanoDrop ND1000 (ThermoScientific, USA). With the use of
QuantiTect Reverse Transcription Kit and oligodT (Qiagen, Ger-
many) we have obtained cDNA from previously isolated mRNA
fraction. The reverse transcription reaction was antedated by addi-
tional elimination of DNA with the use of the QuantiTect Wipeout
buffer, one of the components of QuantiTec Reverse Transcription
Kit. The matrix that was achieved was free of any contamination
from genomic DNA, amplification of which could falsify the real
time PCR reaction.
Primers design. Primers for the real time PCR reaction: The glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH), VEGFR1,
MCP primers were constructed based on the RTPrimerDB [9].
Primers for DAF, HB-EGF, beta-actin (ACTB) and C3 were con-
structed with the use of Primer 3 software [10] and their specifici-
ty for cDNA was verified in the BLAST database [11]. Additional-
ly, the thermodynamic results of designed primers were checked
against OligoAnalizer software, to confirm the specificity for
achieved primers. Primer sequences, size of achieved reaction
products and melting temperature (Tm) are depicted in Table 2.
Real Time PCR. All reactions were conducted using DyNAmo HS
SYBR Green qPCR Kit (Finnzymes, Finland) and RotorGene 3000
thermocycler (CorbettResearch, Australia). Specificity of achieved
reaction products were checked on 2% agarose gel and second
derivative of melting curve for the PCR reaction.
To establish the levels of given transcripts in studied sample
we have constructed standard curves generated by the Ct (value
where amplification curve crosses the threshold line ) with seven
subsequent 10 times dilutions of linear DNA, which is the product
of given set of primers. The quality of achieved curves, described
with R2 was contained within 0.9986-0.9992, end the efficiency E
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Table 1. Clinical characterization of studied groups.
of the reaction was within 0.92-1.00. The thermal profile was
based on manufacturer's instructions, regarding the specific
annealing temperature of primers. The relative expression of stud-
ied transcript in given sample was calculated as the ratio of the
measured Ct value to a Ct value for a reference genes with consti-
tutive expression – GAPDH, ACTB (beta actin). Because the use
of different reference genes in different tissues is often a subject of
debates we have verified the adequacy of ACTB with GAPDH
[12]. The levels of both genes was highly correlated, the correla-
tion coefficients for both genes were 0.915 for the consecutive mis-
carriage group and 0.841 for the controls (p<0.0001). The calcula-
tion of Ct values for standards and studied samples and construc-
tion of standard curves was performed with the RotorGene 3000
software.
Statistical analysis. For statistical analysis we have used the Sig-
maStat 3.5 software. For normality of the variables Kolmogorov –
Smirnov test was used and showed non-parametric distibution of
the variables. To compare the relative expression between studied
groups we used the Mann-Whitney test. Correlations between
studied transcripts were assessed by Spearman analysis and p<0.05
was considered statistically significant. 
Results
Achieved results show statistically significant higher
relative expression of factors inhibiting the comple-
ment activation in women with unexplained consecu-
tive miscarriages. Transcripts levels of MCP was 1.45
and DAF was 15.41 times higher in women with con-
secutive miscarriages compared to controls. Tran-
scripts levels  of HB-EGF, despite being higher in con-
trols, failed to reach statistical significance. There was
also no statistically significant difference in relative
expression of VEGFR1. Similarly, the C3 component
of the complement system exhibited no differences
between groups. Table 3 shows the median, and
95%CI for relative transcripts levels. 
The levels of relative expression for MCP and
DAF, when studied with the Spearman test, were pos-
itively correlated both in the control and the studied
group. Additionally, the expression of MCP and DAF
was positively correlated with the C3 expression in
women with two or more unexplained, consecutive
miscarriages, and the C3 component positively corre-
lated with DAF in control, and the observed correla-
tion was stronger in the control. Statistically signifi-
cant correlations were not observed between C3 and
VEGF1 transcripts levels. The correlation coefficients
are depicted in Table 4. 
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Table 2. Forward and reverse primer sequences, size of achieved reaction products and melting temperature
FF – forward primer; REV – reverse primer; Tm – melting temperature 
Table 3. Transctipts levevs of MCP, HB-EGF, DAF, C3 i VEGFR1 showed as median, and 95CI. The target mRNA levels were correct-
ed to the amount ACTB and GAPDH cDNA and expressed as multiplicity of these cDNA copies in calibrator
*Mann-Whitney Rank Sum Test
Discussion
It was the first study in literature which attempted the
verification of a working hypothesis, that in
endometrium of women with two or more unex-
plained, consecutive miscarriages there is an elevated
synthesis of complement system components, com-
pared to fertile women. 
Sugiura-Ogasawara et al. [13] showed that in
women with two miscarriages that exhibited higher lev-
els of C3 and C4 in peripheral blood, the next pregnan-
cy also ended in miscarriage. Based on above results
and our experience we might speculate that the activa-
tion of the complement system occurs in response to the
fetal antigens. There are also suggestions that the abili-
ty to develop increased complement reaction is a result
of the maternal immunological status. 
However, as it was proven in mouse model by Xu
et al. [14], the mortality of homozygous fetuses is
caused by inability to limit the complement cascade
activation. In this process in mice the key role is
played by the Crry protein, which has analogous func-
tion to human DAF and MCP proteins. 
Immunohistologic localization of the human DAF
and MCP proteins have shown that they are present not
only at the maternal-fetal interface, but also in decid-
uas, which might point to a fact that also the maternal
immune system takes an active part in limiting the
complement cascade from developing uncontrolled
and damaging immunologic response to the fetus [15].
The results of current paper indicate that the DAF
and MCP transcripts level are higher in women with
two or more unexplained, consecutive miscarriage
compared to controls. This is at clear odds with the
assumed hypothesis of the increase the complement
cascade in women with unexplained, consecutive mis-
carriages. It is worth pointing out that in a group of
women with two or more unexplained, consecutive
miscarriage the transcription level of factors inhibiting
the complement activation was correlated with the
transcription level of C3. Concurrently the synthesis of
DAF, MCP and C3 proteins in the studied material
might suggest that during the implantation window of
the non-conceptional cycle the synthesis of pro and
anti – activator factors remains in balance. This is fur-
ther confirmed by the correlation observed between C3
and DAF, which is responsible for inhibiting the C3
convertase [1]. 
The expression of DAF and MCP is stimulated by
HB-EGF [3]. In our study the level of transcription for
this gene did not differ among groups. It is however
impossible at this point, to exclude the role of HB-
EGF on the expression of factors controlling the com-
plement activation. The path from HB-EGF transcript
to an active protein is in this situation dependant on
other factors like: protein synthesis, binding to co-
receptor-heparin sulfate, the activity of heparanse and
steroid hormones [4,16]. Earlier works by Krussel et
al. [17] proved that in endometrium there is a synthe-
sis of both the soluble and bound to the cell membrane
VEGFR1, with its maximal expression observed in
midproliferative phase, and minimal at the beginning
of the luteal phase. Although the methods used in our
paper did not differentiate between the specific forms
of the above mentioned receptor, we were able to
demonstrate low – in relation to reference – transcript
levels of VEGFR1 in midluteal phase of the cycle. The
1.6 times lower expression of VEGFR 1 transcript was
accompanied in the group of women with  miscarriage
by higher levels of DAF and MCP, which indirectly
inhibit the secretion of sVEGFR1. However, there was
no statistically significant negative correlation
between those factors in our material. It should be
remembered that comparing just the transcripts levels
we acquire only part of the information regarding the
gene expression. Spliced mRNA transcripts are only
matrix for proteins synthesis, which are often post-
translationally processed (i.e. sVEGFR1). The confir-
mation of achieved results should expected with pro-
tein assays.
To summarise, in women with two or more unex-
plained, consecutive miscarriage the analysis shows
higher transcript levels of genes that encode proteins
that inhibit the complement cascade . Further studies
are needed to confirm the results of the following
study, to precise that this is a reaction to increased
presence of the complement factors, which like C3 are
synthesized in the endometrium.
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Table 4. Spearman Rank Correlation between transcripts levels C3 and DAF, MCP, and VEGFR1 in study groups
NS – statistically not significant
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